Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(18 sites)
United States
UT Southwestern Medical Center, Dallas, Texas Croatia
University Hospital Centre Zagreb, Zagreb Finland
Helsinki University Hospital, Helsinki France
CHU de Nantes Hôtel-Dieu, Nantes Germany
Vivantes Klinikum im Friedrichshein (KFH), Berlin Gerinnungszentrum Rhein-Ruhr, Duisburg Universitätsklinikum Hamburg Eppendorf (UKE), Hamburg India
Christian Medical College Vellore, Vellore, Tamil Nadu St. John's Medical College Hospital, Bengaluru Italy
Azienda Ospedaliera Pugliese Ciaccio, Catanzaro Azienda Ospedaliero Universitaria Careggi - Centro Emofilia, Florence Centro Trombosi e Malattie Emorragiche, ITCCS Humanitas Research Hospital, Milan North Macedonia
Centre for Haemopilia, Institute for transfusion medicine of Republic of North Macedonia, Skopje Serbia
Clinical Center for Serbia Belgrade, Belgrade Spain
Hospital Universitario La Paz, Madrid Hospital Universitario Virgen del Rocio, Seville United Kingdom
St. James's University Hospital, Leeds Last updated October 2025